Breathe BioMedical

Breathe BioMedical, based in Boston, is a wholly owned subsidiary of Picomole, a medical technology company headquartered in Moncton, New Brunswick, Canada. We are currently developing a lung cancer screening test.

In 2005, Picomole was founded in Edmonton, Alberta, as a spin out from the University of Alberta. In 2008, Picomole completed its first gas analyzer prototype. Picomole relocated to Moncton, New Brunswick in 2011, where the first breath sampler prototype was created that same year.

After nationally incorporating in 2013, Picomole ceased operations until 2016, when Picomole refinanced. In 2018, Picomole took a large step in becoming the company that it is today by hiring Dr. Stephen Graham as CEO. Under the guidance of Dr. Graham in 2018, Picomole completed a preliminary study for a lung cancer screening model.

Picomole has now completed a proof of concept (POC) study for lung cancer, and is in the process of completing the breast cancer POC. Picomole is poised to change the way disease is detected for years to come.